Protalix BioTherapeutics (PLX) Institutional Ownership $1.54 +0.03 (+1.99%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$1.55 +0.01 (+0.65%) As of 08/8/2025 07:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Protalix BioTherapeutics (NYSE:PLX)CurrentInstitutional OwnershipPercentage16.53%Number ofInstitutional Buyers(last 12 months)27TotalInstitutional Inflows(last 12 months)$7.91MNumber ofInstitutional Sellers(last 12 months)7TotalInstitutional Outflows(last 12 months)$649.38K Get PLX Insider Trade Alerts Want to know when executives and insiders are buying or selling Protalix BioTherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PLX Institutional Buying and Selling by Quarter Protalix BioTherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/8/2025 Intech Investment Management LLC36,490$54K0.0%N/A0.046% 8/8/2025 Police & Firemen s Retirement System of New Jersey18,554$27K0.0%N/A0.023% 8/8/2025 Geode Capital Management LLC826,333$1.22M0.0%N/A1.038% 8/7/2025 Cascade Financial Partners LLC17,000$25K0.0%N/A0.021% 8/7/2025 Connor Clark & Lunn Investment Management Ltd.496,216$734K0.0%+2.8%0.623% 8/5/2025 Harel Insurance Investments & Financial Services Ltd.26,000$40K0.0%N/A0.033% 7/29/2025 Orin Green Financial LLC61,200$91K0.0%+22.4%0.077% 6/27/2025Goldman Sachs Group Inc.289,461$741K0.0%+482.3%0.364% 5/19/2025Jane Street Group LLC294,318$753K0.0%+159.0%0.370% 5/16/2025Goldman Sachs Group Inc.289,461$741K0.0%+482.3%0.364% Get the Latest News and Ratings for PLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protalix BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/16/2025NewEdge Advisors LLC15,080$39K0.0%N/A0.019% 5/15/2025Cubist Systematic Strategies LLC53,380$137K0.0%+82.1%0.067% 5/15/2025OMERS ADMINISTRATION Corp179,300$459K0.0%N/A0.225% 5/14/2025Hsbc Holdings PLC25,535$64K0.0%-36.2%0.032% 5/12/2025 Connor Clark & Lunn Investment Management Ltd.482,875$1.24M0.0%N/A0.607% 5/8/2025XTX Topco Ltd41,826$107K0.0%N/A0.053% 5/8/2025 GSA Capital Partners LLP209,292$536K0.0%-31.5%0.263% 5/6/2025 Orin Green Financial LLC50,000$128K0.1%-30.6%0.063% 4/30/2025 Stratos Wealth Partners LTD.346,400$887K0.0%+28.3%0.444% 2/17/2025Squarepoint Ops LLC73,940$139K0.0%+33.4%0.100% 2/17/2025Point72 Asia Singapore Pte. Ltd.53,507$101K0.0%+13.7%0.073% 2/17/2025Millennium Management LLC387,921$729K0.0%+3.8%0.527% 2/17/2025Cubist Systematic Strategies LLC29,307$55K0.0%+24.1%0.040% 2/17/2025Bank of America Corp DE33,714$63K0.0%-25.1%0.046% 2/14/2025Jane Street Group LLC113,616$214K0.0%+147.2%0.154% 2/14/2025Northern Trust Corp731,742$1.38M0.0%+1,299.4%0.994% 2/13/2025Marshall Wace LLP101,899$192K0.0%N/A0.138% 2/13/2025Renaissance Technologies LLC1,118,000$2.10M0.0%+17.0%1.518% 2/11/2025Prudential Financial Inc.36,400$68K0.0%N/A0.049% 2/11/2025Virtu Financial LLC34,276$64K0.0%-21.0%0.047% 2/4/2025 Y Intercept Hong Kong Ltd18,818$35K0.0%N/A0.026% 1/22/2025 PFG Investments LLC20,730$39K0.0%N/A0.028% 11/25/2024Sanctuary Advisors LLC37,100$38K0.0%N/A0.050% 11/20/2024Virtu Financial LLC43,388$44K0.0%N/A0.059% 11/15/2024XTX Topco Ltd35,058$36K0.0%N/A0.048% 11/15/2024Jane Street Group LLC45,952$47K0.0%-84.2%0.062% 11/15/2024Point72 Asia Singapore Pte. Ltd.47,073$48K0.0%-30.9%0.064% 11/5/2024 GSA Capital Partners LLP435,213$444K0.0%+8.5%0.592% 9/16/2024Cubist Systematic Strategies LLC32,031$37K0.0%N/A0.044% 9/16/2024Point72 Asia Singapore Pte. Ltd.68,163$80K0.0%N/A0.093% Trump’s national nightmare is here (Ad)Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.Watch the National Emergency broadcast here8/15/2024AQR Capital Management LLC57,106$67K0.0%N/A0.078% 8/15/2024Point72 Asia Singapore Pte. Ltd.68,163$80K0.0%N/A0.093% 8/14/2024Squarepoint Ops LLC137,764$161K0.0%+673.3%0.188% 8/14/2024Cubist Systematic Strategies LLC32,031$37K0.0%N/A0.044% 8/9/2024Renaissance Technologies LLC804,600$941K0.0%-2.4%1.097% 8/8/2024 Ground Swell Capital LLC62,234$73K0.1%N/A0.085% 5/20/2024Virtu Financial LLC157,516$198K0.0%N/A0.215% 5/7/2024 SG Americas Securities LLC21,467$27K0.0%-38.0%0.029% 5/3/2024 GSA Capital Partners LLP493,571$622K0.0%-9.3%0.673% 2/2/2024 Bailard Inc.68,100$121K0.0%N/A0.095% 1/19/2024 Denali Advisors LLC94,700$169K0.1%-14.1%0.132% 11/15/2023 GSA Capital Partners LLP496,781$825K0.1%N/A0.694% 11/13/2023 Connor Clark & Lunn Investment Management Ltd.167,536$278K0.0%+45.0%0.234% 11/7/2023Barclays PLC46,511$77K0.0%+251.6%0.065% 10/27/2023 Allspring Global Investments Holdings LLC137,906$229K0.0%N/A0.193% 10/24/2023 Bank of New York Mellon Corp165,680$275K0.0%+12.8%0.231% 10/13/2023 SG Americas Securities LLC30,008$50K0.0%N/A0.042% 9/21/2023Barclays PLC13,230$26K0.0%+561.5%0.018% 8/11/2023Natixis132,000$264K0.0%N/A0.202% 8/4/2023 American International Group Inc.27,034$54K0.0%N/A0.041% 7/31/2023 Orin Green Financial LLC60,150$120K0.1%N/A0.092% 7/18/2023 Denali Advisors LLC110,200$220K0.1%N/A0.168% 5/10/2023 Connor Clark & Lunn Investment Management Ltd.158,703$333K0.0%N/A0.243% 5/9/2023Aptus Capital Advisors LLC16,010$34K0.0%N/A0.024% 2/7/2023 Commonwealth Equity Services LLC50,100$68K0.0%N/A0.101% 7/26/2022 Capital Performance Advisors LLP25,974$28K0.0%N/A0.055% 5/9/2022 Meitav Dash Investments Ltd.244,332$257K0.0%N/A0.527% 4/18/2022 Spire Wealth Management148,800$158K0.0%+18.3%0.321% 1/31/2022 Commonwealth Equity Services LLC40,290$33K0.0%N/A0.088% 1/14/2022 Spire Wealth Management125,800$113K0.0%+598.9%0.276% 11/15/2021 GSA Capital Partners LLP254,871$339K0.0%N/A0.559% 11/12/2021Credit Suisse AG31,974$43K0.0%-51.5%0.070% 8/18/2021 Meitav Dash Investments Ltd.244,332$467K0.0%N/A0.538% 8/17/2021Walleye Capital LLC346,539$662K0.0%N/A0.764% 8/17/2021Walleye Trading LLC135,000$258K0.0%N/A0.297% 8/17/2021Bridgeway Capital Management LLC393,890$752K0.0%+30.2%0.868% 8/16/2021Morgan Stanley1,861,819$3.56M0.0%+3,723,538.0%4.102% 8/16/2021Credit Suisse AG65,925$126K0.0%+559.3%0.145% 8/13/2021Renaissance Technologies LLC30,075$57K0.0%-94.1%0.066% 8/12/2021XTX Topco Ltd17,148$33K0.0%N/A0.038% 8/11/2021Susquehanna Fundamental Investments LLC66,100$126K0.0%N/A0.146% 8/5/2021 Meitav Dash Investments Ltd.244,332$467K0.0%N/A0.538% (Data available from 1/1/2016 forward) PLX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PLX shares? During the previous two years, 37 institutional investors and hedge funds held shares of Protalix BioTherapeutics. The most heavily invested institutionals were Renaissance Technologies LLC ($2.10M), Northern Trust Corp ($1.38M), Geode Capital Management LLC ($1.22M), Stratos Wealth Partners LTD. ($887K), Jane Street Group LLC ($753K), Goldman Sachs Group Inc. ($741K), and Connor Clark & Lunn Investment Management Ltd. ($734K).Learn more on Protalix BioTherapeutics' institutional investors. What percentage of Protalix BioTherapeutics' stock is owned by institutional investors? 16.53% of Protalix BioTherapeutics' stock is owned by institutional investors. Learn more on PLX's institutional investor holdings. Which institutional investors have been buying Protalix BioTherapeutics' stock? Of the 34 institutional investors that purchased Protalix BioTherapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Geode Capital Management LLC ($826.33K), Northern Trust Corp ($679.45K), Connor Clark & Lunn Investment Management Ltd. ($548.21K), GSA Capital Partners LLP ($530.75K), Goldman Sachs Group Inc. ($479.50K), Jane Street Group LLC ($248.37K), and Virtu Financial LLC ($200.90K). How much institutional buying is happening at Protalix BioTherapeutics? Institutional investors have bought a total of 4,087,502 shares in the last 24 months. This purchase volume represents approximately $7.91M in transactions. Which of Protalix BioTherapeutics' major shareholders have been selling company stock? The following institutional investors have sold Protalix BioTherapeutics stock in the last 24 months: Jane Street Group LLC ($244.31K), GSA Capital Partners LLP ($96.46K), Orin Green Financial LLC ($22K), Point72 Asia Singapore Pte. Ltd. ($21.09K), Hsbc Holdings PLC ($14.49K), Bank of America Corp DE ($11.28K), and Virtu Financial LLC ($9.11K). How much institutional selling is happening at Protalix BioTherapeutics? Institutional investors have sold a total of 418,734 shares in the last 24 months. This volume of shares sold represents approximately $649.38K in transactions. Related Companies Siga Technologies Major Shareholders PureTech Health Major Shareholders Gossamer Bio Major Shareholders Cullinan Therapeutics Major Shareholders Savara Major Shareholders SNDL Major Shareholders MBX Biosciences Major Shareholders aTyr Pharma Major Shareholders COMPASS Pathways Major Shareholders Kamada Major Shareholders This page (NYSE:PLX) was last updated on 8/11/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protalix BioTherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protalix BioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access Sale